Trial intelligence / Profile preview

WIN-901X in Asthma Patients

NCT01820481Phase 2Completed

Sponsor
WhanIn Pharm
Start
Sep 2012
Primary completion
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of WIN-901X in asthma, sponsored by WhanIn Pharm. Started Sep 2012; status: completed.

02

Drugs

WIN-901X
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01820481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01820481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call